Abstract: The sample measuring apparatus includes: a measuring device that measures a sample; a conveyance device that uses cassettes each having a plurality of stages capable of storing a plurality of samples having different sizes, takes out each sample one by one from a cassette serving as a pickup source among the cassettes, conveys the sample to the measuring device, and stores the sample measured by the measuring device into a cassette serving as a placement destination among the cassettes; a sample detector capable of detecting presence or absence of the sample in each stage of each of the cassettes; and a controller that controls the measuring device and the conveyance device based on a result of the detection by the sample detector.

Abstract: A sample measuring apparatus is capable of surely assuring accuracy of aligning a sample. The sample measuring apparatus includes: a measuring device that measures a sample; a conveyance device that conveys the sample to a measurement section of the measuring device along a conveyance path; and a position assurance section into which the position assurance sample held by the conveyance device is fitted by driving of the conveyance device.

Abstract: A fluorine-containing elastomer composition comprising 0.4 to 4.0 parts by weight of a pigment that is a perylene-based compound, a naphthalenecarboxamide-based compound, a pyrimidinetrione-based compound, or a benzimidazolone-based compound, and 0.2 to 5.0 parts by weight of a bisamidoxime compound or 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane, based on 100 parts by weight of a fluorine-containing elastomer having a copolymer composition of (A) 60.0 to 80.0 mol % of tetrafluoroethylene, (B) 19.8 to 39.8 mol % of perfluoro(lower alkyl vinyl ether) or perfluoro(lower alkoxy lower alkyl vinyl ether), and (C) 0.2 to 5.0 mol % of a perfluoro unsaturated nitrile compound.

Abstract: A component supply device includes: a picker base on which a component is to be loaded; a supplier that picks up the component loaded on the picker base and supplies the component to a predetermined position; a detector that detects the component loaded on the picker base; and a hardware processor that determines a state of the component loaded on the picker base, on a basis of information detected by the detector, wherein the hardware processor determines whether the component is a component that is pickable or a component that is unpickable by the supplier on a basis of the state of the component, and calculates an operation amount for adjusting the component that is unpickable to a pickable state and adjusts only a state of the component that is unpickable by an adjuster on a basis of the calculated operation amount.

Abstract: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.

Abstract: A picking device includes: a workpiece holder in which a plurality of workpieces is stacked; a light receiver that receives reflected light from a workpiece stacked in the workpiece holder; a mover that relatively moves the light receiver with respect to the workpiece in such a manner that a distance between the light receiver and the workpiece is adjustable; an arm that picks the workpiece; a first hardware processor that calculates a distance between the light receiver and at least one workpiece among the plurality of workpieces; a second hardware processor that specifies a workpiece as a picking target among the plurality of workpieces or a region where the workpiece exists; and a third hardware processor that adjusts a distance between the light receiver and the workpiece calculated by the first hardware processor by controlling the mover in the region specified by the second hardware processor.

Abstract: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.

Abstract: An object is captured in an image taken by the camera. An external shape of the object is recognized from the image. An internal shape of the object is recognized from the image. Parts information of the object is then determined, using a result of the recognition of the external shape and/or a result of recognition of the internal shape.

Abstract: The present invention is intended to provide a novel biomarker for detecting arteriosclerosis-related disease or for evaluating the stage of progression of arteriosclerosis, and specifically, the present invention relates to a marker for detecting arteriosclerosis-related disease or for evaluating the stage of progression of arteriosclerosis, comprising an NPC2 (Niemann-Pick disease type C2) protein and/or an IGFBP7 (Insulin-like growth factor-binding protein 7) protein.

Abstract: The present invention is intended to provide a novel biomarker capable of detecting aortic aneurysm with high sensitivity, and specifically, the present invention relates to a detection marker of aortic aneurysm, comprising an NPC2 (Niemann-Pick disease type C2) protein and/or an IGFBP7 (Insulin-like growth factor-binding protein 7) protein.

Abstract: The present invention provides a novel antibody targeting TLR9.

Abstract: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.

Abstract: An image forming apparatus includes: a photoconductor; a transfer portion; a photoconductor cleaner that removes residual toner from a surface of the photoconductor; and a first processor that forms a toner patch on the surface of the photoconductor. When the toner patch passes the transfer portion, the transfer portion makes the toner patch stay on the surface of the photoconductor such that toner of the toner patch is able to be supplied to the photoconductor cleaner. The first processor further determines an amount of toner for the toner patch with reference to a circumferential distance the photoconductor travels for a predetermined period of time.

Abstract: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.

Abstract: An object of the present invention is to provide a technique for detecting human TLR7. Human TLR7 in a sample can be detected through an ELISA method or the like using an anti-human TLR7 antibody. The present invention enables use of human TLR7 as a marker indicating the pathological condition of an autoimmune disease.

Abstract: An image forming apparatus includes: a photoconductor; a transfer portion; a photoconductor cleaner that removes residual toner from a surface of the photoconductor; and a first processor that forms a toner patch on the surface of the photoconductor. When the toner patch passes the transfer portion, the transfer portion makes the toner patch stay on the surface of the photoconductor such that toner of the toner patch is able to be supplied to the photoconductor cleaner. The first processor further determines an amount of toner for the toner patch with reference to a circumferential distance the photoconductor travels for a predetermined period of time.

Abstract: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.

Abstract: An image forming apparatus that forms an image on a sheet medium under an operation condition set in accordance with a type of the medium, includes a hardware processor that: detects which of a plurality of assumed types the type of the medium applies to, based on output from a sensor; and performs control under which, before the type of the medium is detected, shift to a quasi-rise state, in which preparation for image formation under a provisional condition has partially been completed, is performed, the provisional condition corresponding to an operation condition corresponding to one of the plurality of assumed types, and after the type of the medium is detected, shift to a rise state, in which preparation for image formation under a fixed condition has been completed, is performed, the fixed condition corresponding to an operation condition corresponding to the detected type.

Abstract: Provided are methods and compositions for maintaining the viability of photoreceptor cells and/or retinal pigment epithelial cells in a subject with an ocular disorder including, for example, age-related macular degeneration (AMD) (e.g., dry or neovascular AMD), retinitis pigmentosa (RP), or a retinal detachment. The viability of the photoreceptor cells and/or the retinal pigment epithelial cells can be preserved by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject having an eye with the ocular condition. The compositions, when administered, maintain the viability of the cells, thereby minimizing the loss of vision or visual function associated with the ocular disorder.

Abstract: An image forming apparatus includes: a photoreceptor; a transferer; a remover that removes toner on a surface of the photoreceptor; and a hardware processor that: performs a control to form a toner image based on a print image on paper according to a first formation condition by using at least the photoreceptor and the transferer; performs a control to form a toner patch on the surface of the photoreceptor according to a second formation condition determined on the basis of the first formation condition at the time of forming the toner image on the paper by the hardware processor; and controls a voltage applied to the transferer to be a voltage at which the toner patch formed on the photoreceptor is not transferred when the toner patch formed on the surface of the photoreceptor passes through a region facing the transferer.